Feb 10, 2017 13:02 pm UTC| Business
ARLINGTON, Va., Feb. 10, 2017 -- FBR Co. (NASDAQ:FBRC) ("FBR" or the “Company"), a leading investment bank serving the middle market, today reported pre-tax income of $5.2 million on revenues of $40.2 million, and a...
Feb 10, 2017 13:02 pm UTC| Business
BRIDGEWATER, N.J., Feb. 10, 2017 -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that the Company will release its fourth quarter and full year 2016 financial results on Tuesday, February 21, 2017 before the...
iTeos Therapeutics to Present at the 2017 BIO CEO & Investor Conference
Feb 10, 2017 13:01 pm UTC| Business
iTeos Therapeutics to Present at the 2017 BIO CEO Investor Conference Gosselies, Belgium - February 10, 2017 - iTeos Therapeutics SA, a Belgian privately-held biotechnology company applying its expertise in...
Feb 10, 2017 13:01 pm UTC| Business
BEVERLY, Mass., Feb. 10, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Feb 10, 2017 13:01 pm UTC| Business
BEVERLY, Mass., Feb. 10, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Catalyst Biosciences Announces 1-for-15 Reverse Stock Split
Feb 10, 2017 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2017 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced...
Intellipharmaceutics Announces 2016 Year End Results
Feb 10, 2017 13:01 pm UTC| Business
TORONTO, Feb. 10, 2017 -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of...